Headwinds and Tailwinds Ahead for Value-Based Agreements

Moderator:

Faculty:

Understanding the Value-Based Enterprise

Moderator:

Faculty:

The Role of the Patient in Value-Based Agreements

Moderator:

Faculty:

Transitioning from Volume-Based Discounts to Value-Based Agreements

Moderator:

Faculty:

The Simple Explanation on the Inflation Reduction Act and Impact on Healthcare Markets

Moderator:

Faculty:

Transforming Healthcare Delivery with Artificial Intelligence

Moderator:

Faculty:

Succeeding in Value-Based Payment Arrangements: ASCO’s Patient Centered Cancer Care Certification Pilot

Moderator:

Faculty:

Access Challenges for Medicaid Patients

Moderator:

Faculty:

Defining the Value-Based Agreement Models Involving Pharma

Moderator:

Faculty:

The Return of the Cancer Moonshot

Moderator:

Faculty:

Pharma Value-Based Programs: What Worked, Failed and Is the Future

Moderator:

Faculty:

Health Equity Integration in Value-Based Care, an Upstream Partnership

Moderator:

Faculty:

If It Works for Corn, it will Work for Cancer: Why Healthcare Needs a Futures Market -- and One is Coming

Moderator:

Faculty:

Future Data Exchange Requirements to Support Value-Based Agreements

Moderator:

Faculty:

Legal and Regulatory Issues Surrounding Value-Based Agreements

Moderator:

Faculty:

Wall Street and Capital Markets and the Impact on Cancer Care

Moderator:

Faculty:

CMS: The Regulator Point of View on Value-Based Agreements

Moderator:

Faculty:

Creating Collaborative Partnerships: Stakeholder Perspectives

Moderator:

Faculty:

Alignment of Patient Support Services to Enable Value-Based Contracting

Moderator:

Faculty:

Comprehensive Value-Based Frameworks and Triangulated Agreements

Moderator:

Faculty:

Value-Based Agreement Roadmap from Strategy to Design Through Implementation

Moderator:

Faculty:

Understanding the Economics of the Oncology Drug Pricing Ecosystem

Moderator:

Faculty:

The Impact of Inflation on the Healthcare Ecosystem

Moderator:

Faculty:

Economic Trends and Forecast in Cancer Care

Moderator:

Faculty:

Clinician Leadership in Transforming Cancer Care

Moderator:

Faculty:

The Survival Guide: Winners and Losers of the IRA

Moderator:

Faculty:

Community Cancer Care and Its Future Path Ahead

Moderator:

Faculty:

Selling the Cell – Cost-Benefit Considerations for Complex Therapeutics

Moderator:

Faculty:

Clinical Research Organizations of the Future

Moderator:

Faculty:

Our Fractured Healthcare System: Can It be Healed?

Moderator:

Faculty:

Unified Leadership Efforts to Address and Shape the Future of Cancer Care

Moderator:

Faculty:

A Year in Review

Moderator:

Faculty:

Addressing the Current PBM Models and Impact on Value-Based Care

Moderator:

Faculty:

Supporting Patients: We Must Do Better

Moderator:

Faculty:

Payers’ Initiatives: Future Impact on Cancer Care

Moderator:

Faculty:

What Is the Role of Centers of Excellence?

Moderator:

Faculty:

Self-Insured Employer Panel

Moderator:

Faculty:

340B Program: Current State and Outcomes

Moderator:

Faculty:

How Long is the Last Mile? Real-World Evidence's Vast Potential and Challenges in Oncology

Moderator:

Faculty:

Pharmaceutical Industry Role in Value-Based Agreements

Moderator:

Faculty:

Precision Medicine’s Role and Impact on Value-Based Agreements

Moderator:

Faculty:

340B Programs: A Look at Solutions

Moderator:

Faculty:

Connecting Patients and Providers: The Increase in Digital Solutions in Access Services

Moderator:

Faculty:

Future Models of Precision Medicine

Moderator:

Faculty:

Disparities and the Impact on Cancer Care

Moderator:

Faculty:

Innovation Incubation: Entrepreneurial Disruption of the Ecosystem

Moderator:

Faculty:

Radiation Oncology: Under Clinical Pathways, Transparency, and with Risk Share

Moderator:

Faculty:

Medication Access, Cost and Adherence – Root Cause of High Cost, Low Quality Health Outcomes

Moderator:

Faculty:

The Business Path: From Innovation to Market Access

Moderator:

Faculty:

Utilization of Pathways in Precision Medicine to Impact Patient Care

Moderator:

Faculty:

Drug Pricing and Transformation Realities and Implications on the Road Ahead

Moderator:

Faculty:

Leadership for Navigation: How Leadership Promotes Values of Navigation for Sustainability

Moderator:

Faculty:

New Site of Cancer Care Models

Moderator:

Faculty:

Disruptive Innovation: Can the Healthcare System Transform from Within?

Moderator:

Faculty:

Biosimilars

Moderator:

Faculty:

Oncology Drug Benefit Designs and Pricing Realities Now and Tomorrow

Moderator:

Faculty:

Pediatrics and the Future in Cancer Care

Moderator:

Faculty:

The Role of Specialty Pharmacists in Cancer Care

Moderator:

Faculty:

The Tragedy of the Commons in Healthcare

Moderator:

Faculty:

New Patient-Centric Cancer Care Models

Moderator:

Faculty:

The Impact Pathways Have on Outcomes and Value

Moderator:

Faculty:

Oncology Drug Supply Channels and the Move to Smart Networks and Supporting Value-Based Agreements

Moderator:

Faculty:

Revenue Cycle Management System and Ability to Manage Value-Based Agreements

Moderator:

Faculty:

Telehealth/Digital Health and Integration into Care Management

Moderator:

Faculty:

Practice Transformation Through Value-Based Analytics

Moderator:

Faculty:

Medically Integrated Pharmacy and Future Models of Integration

Moderator:

Faculty:

Technology Transfer for Cell Therapy and Gene Therapy: Will These Advances Be Provided by Community Hospital Cancer Programs?

Moderator:

Faculty:

Industry Perspectives on Cancer Care

Moderator:

Faculty:

The Evolving Role of Social Determinants of Health in Value-Based Care Goals

Moderator:

Faculty:

Drug/Biologic Development: To Market; To Out-License; To Be Acquired

Moderator:

Faculty:

Advocacy and Emerging Roles in Cancer Care

Moderator:

Faculty:

Payer and Provider Innovative Value-Based Agreement

Moderator:

Faculty:

AI and ML Decision Support Models

Moderator:

Faculty: